Clinical Trial Update: Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of eplerenone and aliskiren in hypertensive patients with left ventricular hypertrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Aliskiren (Aliskiren)
• eplerenone (eplerenone)

Snippet

Sponsor: Nagoya University | Conditions: Hypertensive Left Ventricular Hypertrophy | Phase 4 | Status: UNKNOWN